EGFR and non-small cell lung carcinoma: Another allosteric inhibitor, JBJ-04–125-02, has demonstrated anti L858R, T790M and C797S activity in vitro and in vivo.[63] There has also been a focus on central-nervous system penetration due to the tropism of EGFR mutant NSCLC for the brain.